CMV pp65 (415-429)
CMV pp65 (415-429) is a CEF control peptide that is derived from the Cytomegalovirus (CMV) [1].
Product Specifications
CAS Number
207847-44-7
UNSPSC
12352209
Target
CMV
Type
Peptides
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cmv-pp65-415-429.html
Smiles
O=C(N1[C@@H](CCC1)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C(C)C)C(N[C@@H]([C@H](O)C)C(NCC(NCC(NCC(N[C@@H](C)C(N[C@@H](CCSC)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H]([C@H](O)C)N
Molecular Formula
C38H67N13O13S
Molecular Weight
946.08
References & Citations
[1]Peggs K, et al. Characterization of human cytomegalovirus peptide-specific CD8 (+) T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells. Blood. 2002 Jan 1;99 (1) :213-23.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-D101275-100MG 100 mg
Des-(4-(1-piperidinyl)-2-Butenamide) Dacomitinib-5-hydroxypyrrolidin-2-one
Sign In for Pricing
View Details 
